Clin2
NCT07278037Possibly a fitRecruiting

Tranexamic Acid for Postpartum Hemorrhage Trends

Postpartum HemorrhageDelivery ComplicationCesarean Section ComplicationsPerinatal Problems

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study looks at how tranexamic acid, a medicine to reduce bleeding, is given to people who have heavy bleeding after a cesarean delivery. It may help doctors improve treatment for this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
648 people
Ages
Any age
Study type
Observational

Who can take part

  • Had a cesarean delivery
  • Had heavy bleeding (more than 1000 ml) after delivery
  • Were at least 24 weeks pregnant when giving birth
  • Did not receive tranexamic acid before giving birth
  • Had an anesthesia record available

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05562609Recruiting· Phase 3
Tranexamic acid to reduce heavy bleeding after childbirth

This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.

Mbeya
NCT04304625Recruiting· Phase 3
Tranexamic acid to reduce blood loss after C-section

This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.

Bordeaux
NCT06754371Recruiting· Phase 4
Tranexamic acid to prevent heavy bleeding after C-section in autoimmune disease

This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.

Shanghai, Shanghai Municipality
NCT06010368Not yet recruiting· Phase 3
Comparing two drugs to reduce bleeding during planned c-section

This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.

Ismailia
NCT07362992Recruiting· Early Phase 1
Tranexamic acid gel to reduce bleeding during cesarean

This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.

Holon, Central District
NCT05370820Recruiting· Phase 2
Tranexamic acid to prevent heavy bleeding after C-section

This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.

Washington D.C., District of Columbia

Hear when a new Postpartum Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.